Post-coronary intervention recurrent ischemia in the presence of adequate platelet inhibition by dual antiplatelet therapy: What are we overlooking? [1]

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 11, 2007, Pages 2300-2301

  Gurbel, P A ^a   Bliden, K P ^a   Navickas, I ^b   Cohen, E ^b   Tantry, U S ^a  

^a SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

^b Haemoscope Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PROTEINASE ACTIVATED RECEPTOR 1 INHIBITOR; PURINE P2Y12 RECEPTOR INHIBITOR; THROMBIN; UNCLASSIFIED DRUG;

CONTROLLED STUDY; CORONARY STENT; ELECTIVE SURGERY; FIBRIN CLOT; HEART MUSCLE ISCHEMIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DRUG THERAPY, COMBINATION; HUMANS; ISCHEMIA; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; TREATMENT FAILURE;

EID: 35448976126     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02749.x     Document Type: Letter

References (2)

1. Tantry US, Bliden KP, Gurbel PG. Resistance to antiplatelet drugs: current status and future research. Expert Opin Pharmacother 2005; 6: 2027-45.
2. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US. Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005; 46: 1820-6.